CJC-1295 with DAC has a longer half-life and is typically dosed once or twice weekly at higher amounts (1-2 mg)
View Protocol Complete dosage protocol and reconstitution guide for CJC-1295 DAC (2 mg Vial)
Regular provision of intravenous B12 in such circumstances is necessary for the continuation of life - its not a band-aid
For example, a physician or other qualified healthcare professional might add modifier 97 to a physical therapy service code to indicate that the service was rehabilitative in nature
Risk and Handling Precautions Risk Tier: MODERATE This rating reflects both peptides' bioactive activity at angiogenic and cytoskeletal signaling pathways in preclinical models, the absence of established human safety profiles for either compound, and the additional handling considerations specific to intranasal formulations
Clinics generally advise against starting treatment for anyone who: Is pregnant Has a personal or family history of thyroid cancer Has a history of multiple endocrine neoplasia (MEN) syndrome BMI and health history serve as a useful starting point for this evaluation, not an absolute cutoff, since metabolism and overall wellness also weigh into a provider's decision
